Topic Archives: OraSure (OSUR)

Got a Curzio spam the other day touting his newest CVA newsletter pick: And my newest pick could be the best-performing one of them all…It’s an under-the-radar biotech that recently applied for an FDA emergency use authorization. That’s when the government allows a healthcare product to be sold without having to go through the entire […]

Comments

No comments.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info